Evaluation of the effect of SVF cells and nanofat for autologous fibroblast function in facial rejuvenation

Evaluation of the effect of adipose tissue-derived stromal vascular fraction cells (SVF) and nanofat for the maintenance and improvement of autologous fibroblast function in facial rejuvenation

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200127046282N30

Enrollment

Registered

2023-05-09

Start date

2023-05-05

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin aging. Atrophic disorder of skin

Interventions

Intervention 1: Intervention group: They receive 5 cc of nanofat product along with 10 million fibroblast cells and 10 million autologous SVF cells. Intervention 2: Control group: They receive 5 cc of

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 20-60 Having middle to moderate wrinkles

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding History of cancer Patients with a new history of gel and Botox injections People with Mental Disorders Active infection in the face

Design outcomes

Secondary

Measure	Time frame
Inflammation. Timepoint: After each session. Method of measurement: Questionnaire and visit.;Intensity of pain. Timepoint: Treatment time. Method of measurement: Questionnaire and visit.	—

Primary

Measure	Time frame
The amount of wrinkles. Timepoint: Before treatment and six month after the last session. Method of measurement: Visio face.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem Cell Research Center, Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026